Search Results 151-160 of 15118 for infliximab

  1. 18 Months Later - Your Impact Development

    We did the genetic testing and found out, in fact, Andrew was not able to break down the medications the way most individuals would. Because of this, the ...

  2. Mayo Clinic

    ... . VID-20312294. Home; YouTube - Subway and Patient Cafeteria - Mayo Clinic Patient Video Guide - Minnesota. Double your impact on cancer!

  3. Sarilumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Cholera Vaccine, Live; Dengue Tetravalent Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live ...

  4. Rituximab-arrx (intravenous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Rotavirus Vaccine, Live; SARS-COV-2 (COVID-19) Vaccine, Adenovirus 26 Vector (Janssen); SARS-COV-2 (COVID-19) Vaccine ...

  5. Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) - Mayo Clinic

    Treatment with infliximab, etanercept, adalimumab, tocilizumab, or any other biologic agent within the past 3 months or 5 half lives of the agent (whichever is ...

  6. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    methotrexate [MTX]), immunomodulators, and/or tumor necrosis factor alpha (TNF-?) antagonist therapy (eg, infliximab, adalimumab). This includes ...

  7. Rectal Cancer Surgery Outcomes Enhanced with Colorectal Surgeons David Etzioni

    ... . VID-20096965. Home; Rectal Cancer Surgery Outcomes Enhanced with Colorectal Surgeons David Etzioni. Double your impact on cancer!

  8. A Study to Evaluate the Accuracy of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Participation eligibility · biologic therapy targeted at tumor necrosis factor alpha (eg, infliximab, adalimumab, golimumab, etanercept, certolizumab); ...

  9. Rituximab-pvvr (intravenous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Rotavirus Vaccine, Live; SARS-COV-2 (COVID-19) Vaccine, Adenovirus 26 Vector (Janssen); SARS-COV-2 (COVID-19) Vaccine ...

  10. Ustekinumab-ttwe (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus ...